Briant Fruth

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema et al. · New England Journal of Medicine · 2018 · 952 citations · Full text

Medicine, Immunology, Oncology +10

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer

Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz et al. · JAMA · 2017 · 893 citations · Full text

Medicine, Oncology, Pharmacology +13

Impact of primary (1º) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance).

Alan P. Venook, Donna Niedzwiecki, Federico Innocenti et al. · Journal of Clinical Oncology · 2016 · 333 citations

Medicine, Oncology, Surgery +16

Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma

Shaji Kumar, Betsy LaPlant, Wee Joo Chng et al. · Blood · 2014 · 255 citations · Full text

Medicine, Oncology, Pharmacology +13

Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial

Karyn A. Goodman, Fang‐Shu Ou, Nathan C. Hall et al. · Journal of Clinical Oncology · 2021 · 129 citations · Full text

Medicine, Nuclear Medicine, Oncology +17